PE51399A1 - Forma hidratada cristalina de la sal de sodio del acido (e)-4,6-dicloro-3-(2-oxo-1-fenilpirrolidin-3-ilideno-metil)-1h-indol-2-carboxilico - Google Patents

Forma hidratada cristalina de la sal de sodio del acido (e)-4,6-dicloro-3-(2-oxo-1-fenilpirrolidin-3-ilideno-metil)-1h-indol-2-carboxilico

Info

Publication number
PE51399A1
PE51399A1 PE1998000149A PE00014998A PE51399A1 PE 51399 A1 PE51399 A1 PE 51399A1 PE 1998000149 A PE1998000149 A PE 1998000149A PE 00014998 A PE00014998 A PE 00014998A PE 51399 A1 PE51399 A1 PE 51399A1
Authority
PE
Peru
Prior art keywords
methyl
ilideno
fenilpirrolidin
carboxilico
indol
Prior art date
Application number
PE1998000149A
Other languages
English (en)
Spanish (es)
Inventor
Zadeo Cimarosti
Paolo Maragni
Original Assignee
Glaxo Wellcome Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Spa filed Critical Glaxo Wellcome Spa
Publication of PE51399A1 publication Critical patent/PE51399A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
PE1998000149A 1997-03-05 1998-03-03 Forma hidratada cristalina de la sal de sodio del acido (e)-4,6-dicloro-3-(2-oxo-1-fenilpirrolidin-3-ilideno-metil)-1h-indol-2-carboxilico PE51399A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9704498.6A GB9704498D0 (en) 1997-03-05 1997-03-05 Chemical compound

Publications (1)

Publication Number Publication Date
PE51399A1 true PE51399A1 (es) 1999-06-07

Family

ID=10808697

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1998000149A PE51399A1 (es) 1997-03-05 1998-03-03 Forma hidratada cristalina de la sal de sodio del acido (e)-4,6-dicloro-3-(2-oxo-1-fenilpirrolidin-3-ilideno-metil)-1h-indol-2-carboxilico

Country Status (29)

Country Link
EP (1) EP0966463A1 (xx)
JP (1) JP2001513796A (xx)
KR (1) KR20000075907A (xx)
CN (1) CN1249750A (xx)
AP (1) AP9901637A0 (xx)
AR (1) AR011178A1 (xx)
AU (1) AU6825198A (xx)
BG (1) BG103779A (xx)
BR (1) BR9808305A (xx)
CA (1) CA2282851A1 (xx)
CO (1) CO4940415A1 (xx)
EA (1) EA199900710A1 (xx)
EE (1) EE9900387A (xx)
GB (1) GB9704498D0 (xx)
HR (1) HRP980114A2 (xx)
HU (1) HUP0002109A2 (xx)
ID (1) ID24207A (xx)
IL (1) IL131489A0 (xx)
IS (1) IS5166A (xx)
NO (1) NO994303L (xx)
NZ (1) NZ337315A (xx)
OA (1) OA11154A (xx)
PE (1) PE51399A1 (xx)
PL (1) PL335652A1 (xx)
SK (1) SK119699A3 (xx)
TR (1) TR199902117T2 (xx)
WO (1) WO1998039327A1 (xx)
YU (1) YU43499A (xx)
ZA (1) ZA981791B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9704499D0 (en) * 1997-03-05 1997-04-23 Glaxo Wellcome Spa Method of manufacture
GB9825988D0 (en) 1998-11-27 1999-01-20 Pfizer Ltd Indole derivatives
GB9915231D0 (en) 1999-06-29 1999-09-01 Pfizer Ltd Pharmaceutical complex
US9737531B2 (en) 2012-07-12 2017-08-22 Glytech, Llc Composition and method for treatment of depression and psychosis in humans
RU2020100230A (ru) 2017-06-12 2021-07-13 Глитек Ллс. Лечение депрессии антагонистами nmda и антагонистами d2/5-ht2a или селективными антагонистами 5-нт2a

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9321221D0 (en) * 1993-10-14 1993-12-01 Glaxo Spa Heterocyclic compounds

Also Published As

Publication number Publication date
IL131489A0 (en) 2001-01-28
NO994303L (no) 1999-11-03
EA199900710A1 (ru) 2000-04-24
BR9808305A (pt) 2000-05-16
EE9900387A (et) 2000-04-17
ID24207A (id) 2000-07-13
HUP0002109A2 (hu) 2001-04-28
SK119699A3 (en) 2000-05-16
IS5166A (is) 1999-08-27
PL335652A1 (en) 2000-05-08
TR199902117T2 (xx) 2000-03-21
AU6825198A (en) 1998-09-22
OA11154A (en) 2003-04-16
CN1249750A (zh) 2000-04-05
NZ337315A (en) 2001-02-23
BG103779A (en) 2000-06-30
HRP980114A2 (en) 1998-12-31
JP2001513796A (ja) 2001-09-04
KR20000075907A (ko) 2000-12-26
EP0966463A1 (en) 1999-12-29
NO994303D0 (no) 1999-09-03
GB9704498D0 (en) 1997-04-23
CO4940415A1 (es) 2000-07-24
AP9901637A0 (en) 1999-09-30
ZA981791B (en) 1999-09-03
CA2282851A1 (en) 1998-09-11
WO1998039327A1 (en) 1998-09-11
AR011178A1 (es) 2000-08-02
YU43499A (sh) 2000-12-28

Similar Documents

Publication Publication Date Title
DK0749424T3 (da) Naphthalenderivater som prostaglandin-I2-agonister
PE51399A1 (es) Forma hidratada cristalina de la sal de sodio del acido (e)-4,6-dicloro-3-(2-oxo-1-fenilpirrolidin-3-ilideno-metil)-1h-indol-2-carboxilico
GR3033158T3 (en) Forming stable aqueous solutions of stannous compounds
CA2071999A1 (en) Process for producing salt of aminocarboxylic acid
BR9901542A (pt) Processo para o preparo de soluções aquosas de metioninato de sódio e uso destas soluções na produção de um granulado.
BR9507231A (pt) Uso de derivados de ácido carboxílico para a produção de drogas
PE20030389A1 (es) PROCEDIMIENTO DE PREPARACION DE DERIVADOS 4,4'-DICETO-ß-CAROTENO
BR0015344A (pt) Método para redução de nìquel
ATE323602T1 (de) Bildaufzeichnungsmaterial und flachdruckplatte mit diesem bildaufzeichnungsmaterial
ES2135040T3 (es) Composiciones solidas que contienen sales de oxido de amina-acido maleico.
ES2148475T3 (es) Procedimiento para elaborar formulaciones solidas que contienen agentes tensioactivos de oxidos de aminas.
DK1663165T3 (da) Forbedret stearatsammensætning og fremgangsmåde til fremstilling deraf
ES2171706T3 (es) Procedimiento para la obtencion de sales substituidas del acido 4,4'-diaminoestilben-2,2'-disulfonico.
ES8104213A1 (es) Procedimiento para la preparacion de acido 4,4'dinitro es- tilben-2,2'-disulfonico y sus sales
HUT34947A (en) Process for the production of benzoic acid-derivatives of antimicrobial activity
CO4980899A1 (es) Proceso para la sintesis de los compuestos intermediarios de cloropurina
BRPI0115076B8 (pt) preparação farmacêutica, sua aplicação farmacêutica, bem como processo para preparação da mesma
TR199800860T2 (xx) Bir klavulanik asit tuzu �retimi.
ES2169891T3 (es) Procedimiento para la produccion de compuestos de alcoxicarboniltioarilio.
PE20000271A1 (es) Composicion farmaceutica de (1s,4r)-cis-4-[2-amino-6-(ciclopropilamino)-9h-purin-9-il]-2-ciclopenteno-1-metanol
ATE136801T1 (de) Verfahren zur dehalogenierung von organoverbindungen
JPS572276A (en) 1-methyl-5- n-alkyl-n-chloroacetylamino pyrazole-4- carboxylic acid ester derivative, its preparation, and herbicide for paddy rice field
DE69608260T2 (de) Wässrige spectinomycinborat-auflösung
CO4180620A1 (es) Proceso para preparar formulaciones solidas que contienen tensioactivos de oxido de amina, que comprende una sal so- luble en agua de acido maleico-oxido de amina
ES2109859B1 (es) Nuevos derivados arilpropionicos con accion analgesica y procedimiento para su obtencion.

Legal Events

Date Code Title Description
FC Refusal